Carna Biosciences, Inc. (TYO:4572)

Carna Biosciences Revenue

Carna Biosciences had revenue of 217.37M JPY in the quarter ending June 30, 2026, with 101.91% growth. This brings the company's total for the last twelve months to 729.00M, up 27.45% year-over-year. In the year 2025, Carna Biosciences had annual revenue of 579.00M, down -8.96%. That makes Carna Biosciences the 40,210th largest company in the world by revenue and 3,815th in Japan.

• Revenue (ttm): 729.00M
• Revenue Growth: +27.45%
• P/S Ratio: 11.13
• Revenue / Employee: 11.95M
• Employees: 61
• Market Cap: 8.14B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States of America 259.61M 44.8%
• Japan 169.19M 29.2%
• China 96.55M 16.7%
• Europe 47.71M 8.2%
• Others 5.99M 1.0%

Fiscal year ended Dec 31, 2025 See the full Carna Biosciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	579.00M	-57.00M	-8.96%
Dec 31, 2024	636.00M	-989.00M	-60.86%
Dec 31, 2023	1.63B	239.00M	17.24%
Dec 31, 2022	1.39B	-631.00M	-31.28%
Dec 31, 2021	2.02B	884.00M	78.02%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error